| OTC Markets: DVOX
DynaVox, Inc. develops and markets software, devices and content to assist people in overcoming their speech, language or learning disabilities. Its products serve two areas within the broader assistive technology industry: speech generating technology and special education software for students with special learning needs. The speech generating devices provide a graphical user interface to convert user input in the form of pictorial symbols or text into synthesized and digitized speech. These devices are used by those who are unable to speak, such as adults with amyotrophic lateral sclerosis, or ALS, often referred to as Lou Gehrig's disease, strokes or traumatic brain injuries and children with cerebral palsy, autism or other disorders. The special education software provides robust authoring tools for creating both communication and educational activities translating text-based curriculum into a symbol-based visual presentation for students with a variety of cognitive and physical disabilities. This software is used by children with cognitive challenges, such as those caused by autism, Down syndrome or brain injury; physical challenges, such as those caused by cerebral palsy or other neuromuscular disorders; as well as by children with learning disabilities, such as severe dyslexia. The company was founded on December 16, 2009 and is headquartered in Pittsburgh, PA.